analysis_en

Yesterday's Flash PMIs for September marginally disappointed analysts, lending credence to worries that there might be a slowing in the pace of the recovery. The figures also affirmed a trend among developed nations, with manufacturing…
Read More

NZDCHF has seen a gradual ascension from the yearly lows witnessed in March. Prices have failed in an attempt to break out of the upper regression line, leading to a move to the median regression. Further weakness in the pair has seen a…
Read More

Inventories Fall Again Crude oil prices came back under offer this week. This was despite the latest weekly update from the EIA showing a further drawdown in us crude stores. The Energy Information Administration report showed that in…
Read More

Beaten Down Dollar Back with a Vengeance The US index capped its fourth positive session as it closed 0.45% higher yesterday. The main significance is that it remained above the psychological 94 handle. Investors have turned to the…
Read More

The precious metal remains in a bearish move after earlier this week, price failed to hold above the 1900 level. A brief retracement saw prices testing the 1911.50 level. But with no further room to go, gold prices reversed direction.…
Read More

Crude oil prices are trading with some modest gains on Wednesday. This is after earlier in the week, a weaker inventory report from the American Petroleum Institute (API) saw price falling. For the moment, oil prices are holding on to…
Read More

The British pound sterling has declined for the past three sessions. However, price action on Wednesday could possibly see a flat close. A Doji formation following three days of strong declines could offer some rebound in the near term.…
Read More

The common currency continues to embark on a correction as price action failed to hold near the technical support level of 1.1715. The breakdown below this key support level could potentially mark further declines in the medium term.…
Read More

Shares in US pharmaceutical firm Pfizer are trading almost 1% higher pre-market on Wednesday. Pfizer and its German partner BioNTech have been working on a COVID vaccine. They have recently announced that they could be the first to…
Read More